Drug profile · INN
coronavirus (sars-cov-2) rna vaccine (active ingredients: tozinameran and famtozinameran)
COMIRNATY RTU (NOTE 2) (BIVALENT, ORIGINAL/OMICRON BA.4-5) PARTIAL CHANGE APPROVAL
coronavirus (sars-cov-2) rna vaccine (active ingredients: tozinameran and famtozinameran) (COMIRNATY RTU (NOTE 2) (BIVALENT, ORIGINAL/OMICRON BA.4-5) PARTIAL CHANGE APPROVAL) is an FDA-listed pharmaceutical active ingredient.
Drug details — coronavirus (sars-cov-2) rna vaccine (active ingredients: tozinameran and famtozinameran)
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.78
Quick answer
coronavirus (sars-cov-2) rna vaccine (active ingredients: tozinameran and famtozinameran) (COMIRNATY RTU (NOTE 2) (BIVALENT, ORIGINAL/OMICRON BA.4-5) PARTIAL CHANGE APPROVAL) is an FDA-listed pharmaceutical active ingredient.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| PMDA | approved | — |
Frequently asked questions
What is coronavirus (sars-cov-2) rna vaccine (active ingredients: tozinameran and famtozinameran)?
coronavirus (sars-cov-2) rna vaccine (active ingredients: tozinameran and famtozinameran) (COMIRNATY RTU (NOTE 2) (BIVALENT, ORIGINAL/OMICRON BA.4-5) PARTIAL CHANGE APPROVAL) is an FDA-listed pharmaceutical active ingredient.
What is the brand name for coronavirus (sars-cov-2) rna vaccine (active ingredients: tozinameran and famtozinameran)?
COMIRNATY RTU (NOTE 2) (BIVALENT, ORIGINAL/OMICRON BA.4-5) PARTIAL CHANGE APPROVAL is a marketed brand name for coronavirus (sars-cov-2) rna vaccine (active ingredients: tozinameran and famtozinameran). Check FDA Drugs@FDA for the current US label holder and prescribing information.